Tuesday, January 3, 2017

My NEW Featured Pick is Globalink, Ltd. (GOBK) who now supply and control over 20% of the World's supply of gingko leaves, a crucial key raw material used in multiple pharmaceutical drug preparations ranging from Alzheimer's disease, Lyme disease, chemotherapy, depression, asthma, bronchitis, glaucoma, chronic fatigue syndrome, schizophrenia and heart disease! Insiders own almost 50% of the stock, they are holding onto their shares, they know what's coming! Follow the insiders! Globalink, Ltd. (GOBK) first harvest of 60 tons of gingko leaves has already been pre-sold, such is the the demand for this pharmaceutical raw material. The company is experiencing phenomenal growth, in recent SEC filings, Globalink (GOBK) is expanding and developing a gingko plantation that comprises approximately 1,553 acres, capable of producing up to 5,600 tons of dried gingko leaves per year making it one of the largest independent producers of gingko leaves in China. At current market prices, that's more than $300 million worth of gingko leaves. Globalink (GOBK), utilizing modern scientific and technical procedures to control the entire growing process has attracted attention from pharmaceutical companies, health supplement manufacturers, and industry experts. Many companies have visited the plantation and have expressed interest in partnerships. Already 2 large global companies have supply and distribution partnerships, one being NASDAQ traded The Carlyle Group (CG) who through it's 100% owned subsidiary NBTY has revenues of over 3 BILLION dollars. Long term supply contracts are forecast to be forthcoming with ALL major BIG PHARMAS who rely on the raw material. Looking at monster revenues Globalink (GOBK) also has had the foresight to start it's own biotech company which it recently incorporated named Globalink (Zhejiang) Bio-Technology Co which is engaged in the research and development, cultivation, extraction, and application of gingko trees and other economic plants. Incredibly Globalink, Ltd. (GOBK) also runs a thriving tourism business between Asia and North America that alone would make any company proud, however all this is DWARFED by the magnitude of it's BOOMING gingko plantation! Now is the time to buy shares of GOBK, while it is under the radar, soon it will likely become a household name in the pharmaceutical industry and you will never see it's share price in the penny range again. Look for it's dominance in the gingko business to lead this stock to dollars and an uplisting to a senior exchange or even a buyout by a big pharma.


I've made tens of thousands of dollars trading Penny Stocks, I'm not some famous Wall Street trader, but I'm very good at what I do! Not one of my DarthTraderWins FEATURED PICKS have ever lost, that is verifiable! 

DarthTraderWins WINNING STREAK

I AM THE BEST, HOTTEST STOCK PICKER IN THE NATION, FOLLOW ME ON TWITTER, when I select a new featured stock pick I tweet it to you!

I MOVE THE MARKETS, many picks soar hundreds of percent, some days I'll give you 2 or 3 picks that are triple digit gainers. No-one else can do that or even come close! I NEVER lose! MY NEW PICK IS: Globalink, Ltd. (GOBK), read the highlights below, it will be BIG WINNER number 20 in row, do not get left behind!




My NEW Featured Pick is Globalink, Ltd. (GOBK) who now supply and control over 20% of the World's supply of gingko leaves, a crucial key raw material used in multiple pharmaceutical drug preparations ranging from Alzheimer's disease, Lyme disease, chemotherapy, depression, asthma, bronchitis, glaucoma, chronic fatigue syndrome, schizophrenia and heart disease! 

Insiders own almost 50% of the stock, they are holding onto their shares, they know whats coming! Follow the insiders!
Globalink, Ltd. (GOBK) first harvest of 60 tons of gingko leaves has already been pre-sold, such is the the demand for this pharmaceutical raw material. The company is experiencing phenomenal growth, in recent SEC filings, Globalink (GOBK) is expanding and developing a gingko plantation that comprises approximately 1,553 acres, capable of producing up to 5,600 tons of dried gingko leaves per year making it one of the largest independent producers of gingko leaves in China. At current market prices, that's more than $300 million worth of gingko leaves.
Globalink (GOBK), utilizing modern scientific and technical procedures to control the entire growing process has attracted attention from pharmaceutical companies, health supplement manufacturers, and industry experts. Many companies have visited the plantation and have expressed interest in partnerships.
Already 2 large global companies have supply and distribution partnerships, one being NASDAQ traded The Carlyle Group (CG) who through it's 100% owned subsidiary NBTY has revenues of over 3 BILLION dollars. Long term supply contracts are forecast to be forthcoming with ALL major BIG PHARMAS who rely on the raw material.

Looking at monster revenues Globalink (GOBK) also has had the foresight to start it's own biotech company which it recently incorporated named Globalink (Zhejiang) Bio-Technology Co which is engaged in the research and development, cultivation, extraction, and application of gingko trees and other economic plants. 

Incredibly Globalink, Ltd. (GOBK) also runs a thriving tourism business between Asia and North America that alone would make any company proud, however all this is DWARFED by the magnitude of it's BOOMING gingko plantation! Now is the time to buy shares of GOBK, while it is under the radar, soon it will likely become a household name in the pharmaceutical industry and you will never see it's share price in the penny range again. Look for it's dominance in the gingko business to lead this stock to dollars and an uplisting to a senior exchange or even a buyout by a big pharma.


More Info on Globalink, Ltd. (GOBK)



Yearly Revenues projected to be over $300 MILLION within 5 years!

Insiders own almost 50% of the tiny share structure

Very limited number of shares only 45M O/S

A tiny float of 5M (which means that this stock could rise very quickly as investors compete for shares)

Assets of over 1.5 MILLION dollars relating to it's tourism business (NOT INCLUDING anything gingko)

No dilution, with minimal debt

Look for BIG PHARMA partnerships coming, uplisting and massive percentage rise in it's stock price.


About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!


Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr


If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.